000 01265 a2200337 4500
005 20250517035531.0
264 0 _c20160429
008 201604s 0 0 eng d
022 _a1748-6963
024 7 _a10.2217/nnm.15.27
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSengupta, Aritra
245 0 0 _aDelivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.
_h[electronic resource]
260 _bNanomedicine (London, England)
_c2015
300 _a1775-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCell Line, Tumor
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLasers
650 0 4 _aNanoparticles
_xadministration & dosage
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aRNA, Small Interfering
_xadministration & dosage
650 0 4 _aSoot
_xadministration & dosage
700 1 _aMezencev, Roman
700 1 _aMcDonald, John F
700 1 _aPrausnitz, Mark R
773 0 _tNanomedicine (London, England)
_gvol. 10
_gno. 11
_gp. 1775-84
856 4 0 _uhttps://doi.org/10.2217/nnm.15.27
_zAvailable from publisher's website
999 _c24988020
_d24988020